Cataract Surgery in Indian Patients With or Without LenSx® Laser

Alcon

Status: Withdrawn

Conditions: Cataracts

Treatments: Device: LenSx® laser system; Procedure: Phacoemulsification

Study type: Observational

Funder types: Industry

Identifiers

NCT02605408

CTI742-P001

Details and patient eligibility

About

The purpose of this study is to record and analyze the profile and outcome of cataract patients receiving phacoemulsification (phaco) and artificial intraocular lens (IOL) implantation with or without femtosecond laser-assisted cataract surgery (FLACS) in Indian tertiary medical centers.

Full description

Legitimate patients will receive Standard of Care (SOC) phacoemulsification treatment for cataract and IOL implantation, with or without using LenSx® technology, with followup for 1 month using SOC postsurgical treatment.

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Agree to undergo phacoemulsification cataract surgery in at least 1 eye;
• Understand and sign an informed consent form;
• Other protocol-specified inclusion criteria may apply.

Exclusion criteria

• Refuse to sign the informed consent form or have incomplete medical records;
• Contraindications for phacoemulsification treatment per Investigator discretion or listed in LenSx® Operator's Manual;
• Contraindications for anterior capsulotomy, phacofragmentation of the lens using the FLACS;
• Other protocol-specified exclusion criteria may apply.

Trial design

0 participants in 1 patient group

Cataract surgery

Description:

Phacoemulsification and artificial IOL implantation with and without LenSx® laser system

Treatment:

Procedure: Phacoemulsification

Device: LenSx® laser system